HomeBusinessIndustrialsAzenta (AZTA) Life Sciences Higher After 4Q Earnings
Azenta (AZTA) Life Sciences Higher After 4Q Earnings

Azenta (AZTA) is a provider of life sciences worldwide, enabling therapies to market faster. George Tsilis discusses AZTA as its trading higher after better-than-expected 4Q earnings. He talks about how AZTA announced a $1.5B share-repurchase program. He notes that the company's 4Q revenue came in at $138.00M versus an estimated $133.72M. He then goes over how AZTA works in areas such as drug development, clinical research, and advanced cell therapies. Tune in to find out more about the stock market today.

Market On Close

15 Nov 2022

ON AIR
education
4:30 pm
Your First Trade
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
education
9:30 am
Your First Trade
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
ON AIR
education
4:30 pm
Your First Trade
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
education
8:00 pm
Your First Trade
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US